Aura Biosciences, Inc. logo

Aura Biosciences, Inc.

1501796

Aura Biosciences is developing a new class of oncology targeted therapies. They focus on delivering therapeutic benefit to various cancer indications with high unmet needs, particularly in ocular and urologic oncology. Their virus-like drug conjugate (VDC) technology is central, with belzupacap sarotalocan as the lead candidate for treating early-stage choroidal melanoma.

86
Meget Pålitelig
Tillitsscore

Offisielt Register

Foretaksnavn
Aura Biosciences, Inc.
Organisasjonsnummer
1501796
MVA Nummer
320271970
Firmastatus
Active
Adresse
80 GUEST STREET, BOSTON, MA 02135
Bransjekoder
Biological Products, (No Diagnostic Substances), 2836

AI Kvalitetsanalyse

Bransje
Biotechnology
SSL/HTTPS
Sikker
Profesjonell E-post
Ja
Kontakt E-post
info@aurabiosciences.com

🌟 Lignende Pålitelige Bedrifter

Metagenomi, Inc.

Metagenomi, Inc. logo
74/100 · Pålitelig

Metagenomi is an in vivo genome editing company creating curative genetic medicines using proprietary technologies. They leverage metagenomics to discover editing tools potentially capable of correcting any type of genetic mutation. The company focuses on diseases with well-understood biology and clear regulatory pathways, and intends to expand their pipeline through genetic editing capabilities.

5959 HORTON STREET, USA
Se profil

ARCTICZYMES TECHNOLOGIES ASA

ARCTICZYMES TECHNOLOGIES ASA logo
80/100 · Meget Pålitelig

ArcticZymes Technologies er et bioteknologiselskap som spesialiserer seg på utvikling og produksjon av enzymer. De tilbyr nukleaser for bioframstilling og molekylær diagnostikk, inkludert Saltaktive nukleaser (SAN). Selskapet er kjent for sine polymeraser og enzymer brukt i forskning og industrielle anvendelser.

Sykehusvegen 23, Norge
Se profil

ACD PHARMACEUTICALS AS

ACD PHARMACEUTICALS AS logo
80/100 · Meget Pålitelig

ACD Pharma is a Norwegian R&D company developing biocontrol products based on bacteriophages, focusing on combating harmful bacteria in animals and humans. They launched Custus®YRS, the world's first bacteriophage product for aquaculture. They collaborate with pharmaceutical and scientific teams to fight antibiotic resistance, extending their advancements across sectors.

Lofoten Bio Centre, Norge10 ansatte
Se profil